Dramatic disease regression in a case of HFrEF with end‐stage renal failure treated with sacubitril/valsartan and SGLT2i

The amount of evidence for guideline‐directed new heart failure (HFrEF) disease‐modifying drugs in the context of chronic kidney disease (CKD) is relatively modest, especially in end‐stage CKD. We report a case of dramatic reverse remodelling and disease regression in a naïve HFrEF young woman on ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Mapelli, Massimo, Mantegazza, Valentina, Ferrari, Cristina, Cimino, Roberto, Maragna, Riccardo, Pontone, Gianluca, Pepi, Mauro, Agostoni, Piergiuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192298/
https://www.ncbi.nlm.nih.gov/pubmed/36907832
http://dx.doi.org/10.1002/ehf2.14344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10192298/
https://www.ncbi.nlm.nih.gov/pubmed/36907832
http://dx.doi.org/10.1002/ehf2.14344

Ejemplares similares